Bio-Techne Corporation (TECH), headquartered in Minneapolis, Minnesota, develops, manufactures, and sells life science ...

Bio-Techne (NASDAQ:TECH) will release its quarterly earnings report on Wednesday, 2025-11-05. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Bio-Techne to report ...

Bio-Techne Corporation TECH is set to release fourth-quarter fiscal 2025 results on Aug. 6, before the opening bell. The life science and diagnostic product maker posted adjusted earnings per share ...

--Bio-Techne Corporation today reported its financial results for the third quarter ending March 31, 2025. Delivered adjusted EPS of $0.56 compared to $0.48 one year ago. Improved pharma end market ...

Bio-Techne (TECH) is back in focus after a recent analyst downgrade that cited softer organic growth and a weaker free cash ...

Bio-Techne TECH reported third-quarter fiscal 2025 adjusted earnings per share (EPS) of 56 cents, which surpassed the Zacks Consensus Estimate by 9.8%. The bottom line improved from the year-ago ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Use of Non-GAAP Financial Measures: This press release contains financial measures that have not been calculated in accordance with accounting principles generally accepted in the U.S. (GAAP). We ...

Bio-Techne reported fiscal third-quarter organic revenue growth of 6% year on year, consisting of 7% organic growth in protein sciences and 2% in diagnostics and spatial biology. Adjusted operating ...

--Bio-Techne Corporation today reported its financial results for the fourth quarter ending June 30, 2025. Full year adjusted EPS was $1.92 versus $1.77 one year ago. Strong performance in our ...